The FDA has approved Eli Lilly's medication Mounjaro for reducing the risk of heart events in individuals with Type 2 diabetes. This approval adds to the drug's existing use for blood sugar management and highlights its potential cardiovascular benefits, as evidenced by recent c…
Nutrition expert Joy Bauer explains the nuances of food cravings, differentiating them from hunger and discussing their potential implications for health. She offers insights on h…
New research indicates that individuals who consistently log their food intake may experience greater weight loss. An analysis of over 5,000 adults using a nutrition-tracking app…
A recent clinical trial from Washington University School of Medicine indicates that a ketogenic diet not only aids weight loss but also significantly improves liver health and bl…
A recent study published in Cell Metabolism suggests that while ketogenic, Mediterranean, and low-fat diets can support weight loss, the ketogenic diet may provide additional bene…
A recent Gallup analysis reveals that five key lifestyle factors significantly influence how users perceive the effectiveness of GLP-1 medications for weight loss. These factors i…
This article examines the potential of GLP-1 receptor agonists, commonly used for type 2 diabetes and obesity, in treating polyendocrine metabolic ovarian syndrome (PMOS). Experts…
A study published in Science Advances reveals that the experimental drug TOFA enables obese mice to lose fat without reducing their food intake or losing muscle mass. The compound…
As the popularity of weight-loss drugs like GLP-1 receptor agonists grows, a black market for the unapproved drug retatrutide has emerged, alarming health experts. Developed by El…
GLP-1 medications, known for their role in treating diabetes and obesity, are being studied for additional health benefits, including improvements in heart health and potential ca…
A recent report from the National Restaurant Association highlights how GLP-1 weight-loss drugs are reshaping beverage choices in restaurants. As health consciousness rises, parti…
The Medicare GLP-1 Bridge program offers eligible beneficiaries access to weight loss drugs at a reduced cost of $50 per month. However, patients with certain medical conditions,…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
Beauty companies are racing to address the newly coined term 'Ozempic face' as they develop treatments for facial volume loss linked to rapid weight loss, further complicating the…
Fitness coach Jacob Zemer outlines key strategies to help adults slow muscle loss as they age. He emphasizes the importance of strength training, adequate protein intake, and qual…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…